share_log

While Individual Investors Own 23% of Cofoe Medical Technology Co.,Ltd. (SZSE:301087), Private Companies Are Its Largest Shareholders With 47% Ownership

While Individual Investors Own 23% of Cofoe Medical Technology Co.,Ltd. (SZSE:301087), Private Companies Are Its Largest Shareholders With 47% Ownership

個人投資者擁有科朗醫療科技股份有限公司(SZSE:301087)23%的股份,而私營公司是其最大股東,持有47%的股份
Simply Wall St ·  2024/11/04 20:57

Key Insights

關鍵洞察

  • The considerable ownership by private companies in Cofoe Medical TechnologyLtd indicates that they collectively have a greater say in management and business strategy
  • A total of 3 investors have a majority stake in the company with 53% ownership
  • 11% of Cofoe Medical TechnologyLtd is held by insiders
  • Cofoe醫療科技有限公司中私人公司的持有量相當可觀,表明他們在管理和業務策略上有更大的發言權。
  • 總共有3位投資者在公司中持有53%的多數股份。
  • 科發醫療科技有限公司的11%股權由內部持有

To get a sense of who is truly in control of Cofoe Medical Technology Co.,Ltd. (SZSE:301087), it is important to understand the ownership structure of the business. We can see that private companies own the lion's share in the company with 47% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

要了解誰真正控制了Cofoe醫療科技有限公司(SZSE:301087),理解公司的持有結構非常重要。我們可以看到,私人公司在公司中持有47%的股份,即它們在對公司的投資中可以獲得最多(或失去最多)的收益。

And individual investors on the other hand have a 23% ownership in the company.

另一方面,個人投資者在公司中擁有23%的股份。

Let's delve deeper into each type of owner of Cofoe Medical TechnologyLtd, beginning with the chart below.

讓我們深入了解科蜂醫療技術有限公司每種所有者類型,從下面的圖表開始。

big
SZSE:301087 Ownership Breakdown November 5th 2024
深交所:301087 所有權分佈 2024年11月5日

What Does The Institutional Ownership Tell Us About Cofoe Medical TechnologyLtd?

機構持股告訴我們關於科蜂醫療技術有限公司的什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構通常在向自己的投資者報告時,會與基準進行比較,因此一旦股票被納入主要指數,他們通常對該股票會更加熱情。我們預期大多數公司在登記時都會有一些機構,尤其是當它們正在增長時。

Cofoe Medical TechnologyLtd already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Cofoe Medical TechnologyLtd's earnings history below. Of course, the future is what really matters.

科佛醫療科技有限公司已經在股份登記中有機構存在。實際上,他們在公司中擁有相當可觀的股份。這表明公司在投資社區中具有一定的可信度。然而,最好還是警惕依賴於機構投資者所帶來的所謂驗證。他們有時也會出錯。如果多家機構同時改變對某隻股票的看法,您可能會看到股價快速下跌。因此,值得查看以下科佛醫療科技有限公司的盈利歷史。當然,未來才是最重要的。

big
SZSE:301087 Earnings and Revenue Growth November 5th 2024
SZSE:301087 2024年11月5日的收益和營業收入增長

Cofoe Medical TechnologyLtd is not owned by hedge funds. Changsha Xiezihao Medical Investment Co., Ltd. is currently the largest shareholder, with 41% of shares outstanding. The second and third largest shareholders are Min Zhang and Changsha Keyuan Tongchuang Enterprise Management Center (Limited Partnership), with an equal amount of shares to their name at 5.8%. Min Zhang, who is the second-largest shareholder, also happens to hold the title of Chief Executive Officer.

Cofoe醫療科技有限公司並不被對沖基金持有。長沙謝子豪醫療投資有限公司目前是最大股東,持有41%的流通股份。第二和第三大股東是張敏和長沙科元通創企業管理中心(有限合夥),他們的股份均爲5.8%。第二大股東張敏還兼任首席執行官。

A more detailed study of the shareholder registry showed us that 3 of the top shareholders have a considerable amount of ownership in the company, via their 53% stake.

對股東登記冊的更詳細研究顯示,三位主要股東在公司擁有相當大的持股比例,達到了53%。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

研究機構持股是一種衡量和篩選股票預期表現的好方法。通過研究分析師的情緒也可以達到相同的目的。 目前我們沒有注意到該股票的分析師覆蓋,因此該公司不太可能被廣泛持有。

Insider Ownership Of Cofoe Medical TechnologyLtd

科福醫療技術有限公司內部所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

儘管內部人的確切定義可能是主觀的,但幾乎所有人都認爲董事會成員是內部人。公司管理層對董事會負責,而後者應代表股東的利益。值得注意的是,有時高層管理人員自己也在董事會中。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內幕所有權表明領導者像真正的公司所有者那樣思考時,這是積極的。然而,高內幕所有權也可能賦予公司內部小集團巨大的權力。在某些情況下,這可能是負面的。

It seems insiders own a significant proportion of Cofoe Medical Technology Co.,Ltd.. It is very interesting to see that insiders have a meaningful CN¥878m stake in this CN¥7.8b business. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling.

看來內部人士持有科富醫療科技有限公司的相當大比例股份。 有趣的是,內部人士在這個78億人民幣的業務中擁有高達87800萬元的實際股份。 大多數人會說這表明與股東之間有很好的一致性,尤其是在這樣規模的公司中。 您可以點擊這裏查看那些內部人士是否在買入或賣出。

General Public Ownership

公衆持股

The general public, who are usually individual investors, hold a 23% stake in Cofoe Medical TechnologyLtd. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

公衆,通常是個人投資者,持有科富醫療科技有限公司23%的股份。 雖然這個群體不一定能決定公司的方向,但確實可以對公司的運行產生真實影響。

Private Company Ownership

私有公司所有權

It seems that Private Companies own 47%, of the Cofoe Medical TechnologyLtd stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

科方醫療技術有限公司的股份總數中,私人公司持有47%。 私人公司可能是關聯方。 有時內部人員通過持有私人公司的股份來對公衆公司產生興趣,而不是以個人的身份。 儘管很難得出任何廣泛的結論,但值得注意作爲進一步研究的領域。

Next Steps:

下一步:

While it is well worth considering the different groups that own a company, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Cofoe Medical TechnologyLtd you should know about.

雖然考慮擁有公司不同群體是非常重要的,但還有其他更重要的因素。 例如,要考慮風險。每家公司都有這些風險,我們發現 Cofoe 醫療科技有限公司 有 2 個你應該知道的警告信號。

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

當然,這可能不是最好的股票購買選擇。因此,請查看這個有趣公司的免費列表。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論